JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weisel, R. D.
Right arrow Articles by Pearson, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weisel, R. D.
Right arrow Articles by Pearson, F. G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 839-849, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Sleeve lobectomy for carcinoma of the lung

RD Weisel, JD Cooper, NC Delarue, TE Theman, TR Todd and FG Pearson

Sleeve lobectomy for non-oat cell carcinoma involving a major bronchus preserves functioning lung tissue and, in carefully selected patients, provides long-term survival comparable to pneumonectomy. Seventy patients underwent sleeve lobectomy between 1967 and 1978. Twenty-seven patients were considered compromised (Group I) because they had severe respiratory impairment which contraindicated pneumonectomy. Forty-three patients were considered uncompromised (Group 2) and underwent elective sleeve lobectomy. Seventy patients with a similar non-oat cell carcinoma involving the proximal bronchi underwent pneumonectomy (Group 3) during this period. Perioperative complications occurred more frequently in Group 1 (59%) than in Group 2 (21%) or Group 3 (23%). Both periopeative mortality rate and the incidence of bronchial disruption (bronchovascular and bronchopleural fistulas) were higher in Group I (19% and 22%) than in Group 2 (9% and 5%) or Group 3 (3% and 7%). Survival depended primarily on the surgeon's ability to perform a complete resection of the tumor. An incomplete resection resulted when tumor was found in the highest lymph node or in the last bronchial resection margin when paraffin sections were reviewed. The 5 year survival rate was 18% for compromised patients (Group 1) who underwent complete resection, and there were no survivors among patients undergoing incomplete resections. Uncompromised patients ( Group 2) had a 5 year survival rate of36% with complete and 12% with incomplete resections. Pneumonectomy patients (Group 3) had a 64% 5 year survival rate with a complete resection and 16% with an incomplete resection. The stage of the disease at the time of operation had a profound effect on the survivail. There was no difference inthe 5 and 8 year survival rates between uncompromised patients undergoing sleeve resection ( Group 2) and patients undergoing peneumonectomy (Group 3) for comparable stage of their disease. A careful pre- and postoperative functional assessment revealed that pulmonary performance was improved in 44% of Group 1, 63% of Group 2, and only 14% of Group 3 patients. Patients wiht impaired pulmonary reserve underwent sleeve lobectomy with an adequate disease-free interval when complete tumor excision was possible. Uncompromised patients whose extensive disease required incomplete resection had palliation by sleeve lobectomy equivalent to that by pneumonectomy. When complete t-mor resection was possible, patients with uncompromised pulmonary reserve had a perioperative complication rate and long-term survival equivalent to that of pneumonectomy while preserving pulmonary parenchyma, which permitted an improvement in postoperative pulmonary performance.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
H. F. Lausberg, T. P. Graeter, D. Tscholl, O. Wendler, and H.-J. Schafers
Bronchovascular Versus Bronchial Sleeve Resection for Central Lung Tumors
Ann. Thorac. Surg., April 1, 2005; 79(4): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Fadel, B. Yildizeli, A. R. Chapelier, I. Dicenta, S. Mussot, and P. G. Dartevelle
Sleeve lobectomy for bronchogenic cancers: factors affecting survival
Ann. Thorac. Surg., September 1, 2002; 74(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, and F. Calabro
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases
Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 888 - 893.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. F. Lausberg, T. P. Graeter, O. Wendler, S. Demertzis, D. Ukena, and H.-J. Schafers
Bronchial and bronchovascular sleeve resection for treatment of central lung tumors
Ann. Thorac. Surg., August 1, 2000; 70(2): 367 - 371.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Yatsuyanagi, S. Hirata, K. Yamazaki, T. Sasajima, and Y. Kubo
Anastomotic complications after bronchoplastic procedures for nonsmall cell lung cancer
Ann. Thorac. Surg., August 1, 2000; 70(2): 396 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. End, P. Hollaus, A. Pentsch, W. Brannath, D. Janakiev, M. R. Mueller, N. Pridun, and E. Wolner
Bronchoplastic procedures in malignant and nonmalignant diseaseMultivariable analysis of 144 cases
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 119 - 127.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Tronc, J. Gregoire, J. Rouleau, and J. Deslauriers
Long-term results of sleeve lobectomy for lung cancer
Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 550 - 556.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, and H. Matsuoka
How should interlobar pleural invasion be classified? prognosis of resected T3 non-small cell lung cancer
Ann. Thorac. Surg., December 1, 1999; 68(6): 2049 - 2052.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Okada, N. Tsubota, M. Yoshimura, Y. Miyamoto, H. Matsuoka, S. Satake, and H. Yamagishi
EXTENDED SLEEVE LOBECTOMY FOR LUNG CANCER: THE AVOIDANCE OF PNEUMONECTOMY
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 710 - 714.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Kruger, K. Uschinsky, K. Hassler, and C. Engelmann
Postoperative complications after bronchoplastic procedures in the treatment of bronchial malignancies
Eur. J. Cardiothorac. Surg., July 1, 1999; 14(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H.-C. Suen, B. F. Meyers, T. Guthrie, M. S. Pohl, S. Sundaresan, C. L. Roper, J. D. Cooper, and G. A. Patterson
Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies
Ann. Thorac. Surg., June 1, 1999; 67(6): 1557 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Ph. Icard, J.F. Regnard, L. Guibert, P. Magdeleinat, B. Jauffret, and Ph. Levasseur
Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: a series of 110 consecutive cases
Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 426 - 432.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. C. M. Pitz, A. B. de la Riviere, H. R. J. Elbers, C. J. J. Westermann, and J. M. van den Bosch
Results of Resection of T3 Non-Small Cell Lung Cancer Invading the Mediastinum or Main Bronchus
Ann. Thorac. Surg., October 1, 1996; 62(4): 1016 - 1020.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. Bueno, J. C. Wain, C. D. Wright, A. C. Moncure, H. C. Grillo, and D. J. Mathisen
Bronchoplasty in the Management of Low-Grade Airway Neoplasms and Benign Bronchial Stenoses
Ann. Thorac. Surg., September 1, 1996; 62(3): 824 - 828.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. A. Gaissert, D. J. Mathisen, A. C. Moncure, A. D. Hilgenberg, H. C. Grillo, and J. C. Wain
SURVIVAL AND FUNCTION AFTER SLEEVE LOBECTOMY FOR LUNG CANCER
J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 948 - 953.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
G. Massard, A. Dabbagh, P. Dumont, R. Kessler, N. Roeslin, J.-M. Wihlm, and G. Morand
Are Bilobectomies Acceptable Procedures?
Ann. Thorac. Surg., September 1, 1995; 60(3): 640 - 645.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
T. M. Anderson and J. I. Miller Jr
Use of Pleura, Azygos Vein, Pericardium, and Muscle Flaps in Tracheobronchial Surgery
Ann. Thorac. Surg., September 1, 1995; 60(3): 729 - 733.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
T. M. Anderson and J. I. Miller Jr
Surgical Technique and Application of Pericardial Fat Pad and Pericardiophrenic Grafts
Ann. Thorac. Surg., June 1, 1995; 59(6): 1590 - 1591.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Mehran, J. Deslauriers, M. Piraux, M. Beaulieu, C. Guimont, and J. Brisson
Survival related to nodal status after sleeve resection for lung cancer
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 576 - 583.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1979 by The American Association for Thoracic Surgery.